WOMEN 'S HEALTH AND MENOPAUSE : - National Heart, Lung ...

42 Polo-Kantola P, Portin R, Polo O, Helenius H, Irjala
K, Erkkola R. The effect of short-term estrogen
replacement therapy on cognition: a randomized,
double-blind, cross-over trial in postmenopausal
women. Obstet Gynecol 1998;91(3):459–66.
43 Derby CA, Hume AL, McPhillips JB, Barbour MM,
Carleton RA. Prior and current health characteristics
of postmenopausal estrogen replacement therapy
users compared with nonusers. Am J Obstet
Gynecol 1995;173(2):544–50.
44 Rossouw JE. What we still need to learn about hormone
replacement therapy. Infert and Reprod Med
Clin North Amer 1999;10:189–209.
45 van Dujin CM. Epidemiology of the dementias: recent
developments and new approaches. J Neurosurg
Psychiatry 1996;60:478–88.
46 Jorm AF, Korten AE, Henderson AS. The prevalence
of dementia: a quantitative integration of the literature.
Acta Psychiatr Scand 1987;76(5):465–79.
47 Strittmatter WJ, Saunders AM, Schmechel D, et al.
Apolipoprotein E: high-avidity binding to β-amyloid
and increased frequency of type 4 allele in
late-onset familial Alzheimer disease. Proc Natl
Acad Sci USA 1993;90(5):1977–81.
48 Arendt T, Schindler C, Brückner MK, et al. Plastic
neuronal remodeling is impaired in patients with
Alzheimer’s disease carrying apolipoprotein ε4
allele. J Neurosci 1997;17(2):516–29.
49 Farrer LA, Cupples LA, Haines JL, et al. Effects of
age, sex, and ethnicity on the association between
apolipoprotein E genotype and Alzheimer disease.
JAMA 1997;278(16):1349–56.
50 Bretsky PM, Buckwalter JG, Seeman TE, et al.
Evidence for an interaction between apolipoprotein
E genotype, gender, and Alzheimer disease.
Alzheimer Dis Assoc Disord 1999;13(4):216–21.
51 Pike CJ. Estrogen modulates neuronal Bcl-xL expression
and β-amyloid-induced apoptosis: relevance to
Alzheimer’s disease. J Neurochem
1999;72(4):1552–63.
52 Pacifici R, Brown C, Puscheck E, et al. Effect of surgical
menopause and estrogen replacement on
cytokine release from human blood mononuclear
cells. Proc Natl Acad Sci USA
1991;88(12):5134–8.
53 Stone DJ, Rozovsky I, Morgan TE, Anderson CP,
Hajian H, Finch CE. Astrocytes and microglia
respond to estrogen with increased apoE mRNA in
vivo and in vitro. Exp Neurol 1997;143(2):313–8.
54 Xu H, Gouras GK, Greenfield JP, et al. Estrogen
reduces neuronal generation of Alzheimer
β-amyloid peptides. Nat Med 1998;4(4):447–51.
55 Henderson VW, Paganini-Hill A, Emanuel CK, Dunn
ME, Buckwalter JG. Estrogen replacement therapy
in older women. Comparisons between Alzheimer’s
disease cases and nondemented control subjects.
Arch Neurol 1994;51(9):896–900.
56 Birge SJ. The role of estrogen deficiency in the aging
central nervous system. In: Lobo RA, ed.
Treatment of the postmenopausal woman: basic
and clinical aspects. New York: Raven Press,
1994:153–157.
57 Mortel KF, Meyer JS. Lack of postmenopausal estrogen
replacement therapy and the risk of dementia.
J Neuropsychiatry Clin Neurosci 1995;7(3):334–7.
58 Paganini-Hill A, Henderson VW. Estrogen deficiency
and risk of Alzheimer’s disease in women. Am J
Epidemiol 1994;140(3):256–61.
59 Brenner DE, Kukull WA, Stergachis A, et al.
Postmenopausal estrogen replacement therapy and
the risk of Alzheimer’s disease: a population-based
case-control study. Am J Epidemiol
1994;140(3):262–7.
60 Paganini-Hill A, Henderson VW. Estrogen replacement
therapy and risk of Alzheimer’s disease. Arch
Intern Med 1996;156(19):2213–7.
61 Tang M-X, Jacobs D, Stern Y, et al. Effect of oestrogen
during menopause on risk and age at onset of
Alzheimer’s disease. Lancet
1996;348(9025):429–32.
62 Slooter AJ, Bronzova J, Witteman JC, Van
Broeckhoven C, Hofman A, van Duijn CM.
Estrogen use and early onset Alzheimer’s disease:
a population-based study. J Neurol Neurosurg
Psychiatry 1999;67(6):779–81.
63 Kawas C, Resnick S, Morrison A, et al. A prospective
study of estrogen replacement therapy and the risk
of developing Alzheimer’s disease: the Baltimore
Longitudinal Study of Aging. Neurology
1997;48(6):1517–21.
265